Evidence map›Paper›PMID 35471692›Full record

ReviewGeroScience2022

Obesity as a premature aging phenotype - implications for sarcopenic obesity.

Emily Nunan, Carson L Wright, Oluwayemisi A Semola, Madhan Subramanian, Priya Balasubramanian, Pamela C Lovern, Ibra S Fancher, Joshua T Butcher

Open access · hybridAbstract readReview
In one paragraph

Review in GeroScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emily NunanCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
Carson L WrightCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
Oluwayemisi A SemolaCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
Madhan SubramanianCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
Priya BalasubramanianDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Pamela C LovernCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
Ibra S FancherDepartment of Kinesiology and Applied Physiology, College of Health Sciences, University of Delaware, Newark, DE, USA.
Joshua T ButcherCollege of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA. joshua.butcher@okstate.edu.
Oklahoma State University · USUniversity of Delaware · USUniversity of Oklahoma Health Sciences Center · US

Funding

ZFC3H1 Regulation of Host Defense and Influenza A Virus PathogenesisP20GM103648 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI CHENG, YONG · 2013 to 2022
$22.3M
Skeletal Muscle as a Target for Cardio-Metabolic Disease in Sarcopenic ObesityK01AG064121 · NIA · OKLAHOMA STATE UNIVERSITY STILLWATER · PI BUTCHER, JOSHUA THOMAS · 2020 to 2024
$644k
Targeting adipose tissue thermogenesis for age-related vascular cognitive impairmentK01AG073613 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALASUBRAMANIAN, PRIYA · 2021 to 2025
$596k
Role of Nrf2 and Cellular Senescence in the brainstem in obesity-induced sympathoexcitationR15HL148844 · NHLBI · OKLAHOMA STATE UNIVERSITY STILLWATER · PI SUBRAMANIAN, MADHAN · 2019 to 2019
$442k
NHLBI NIH HHS R15 HL148844NIA NIH HHS K01 AG064121NIA NIH HHS K01-AG064121NIA NIH HHS K01 AG073613NIA NIH HHS K01AG073613NIGMS NIH HHS P20GM103648
6 · The paper itself

Abstract

Obesity and aging have both seen dramatic increases in prevalence throughout society. This review seeks to highlight common pathologies that present with obesity, along with the underlying risk factors, that have remarkable similarity to what is observed in the aged. These include skeletal muscle dysfunction (loss of quantity and quality), significant increases in adiposity, systemic alterations to autonomic dysfunction, reduction in nitric oxide bioavailability, increases in oxidant stress and inflammation, dysregulation of glucose homeostasis, and mitochondrial dysfunction. This review is organized by the aforementioned indices and succinctly highlights literature that demonstrates similarities between the aged and obese phenotypes in both human and animal models. As aging is an inevitability and obesity prevalence is unlikely to significantly decrease in the near future, these two phenotypes will ultimately combine as a multidimensional syndrome (a pathology termed sarcopenic obesity). Whether the pre-mature aging indices accompanying obesity are additive or synergistic upon entering aging is not yet well defined, but the goal of this review is to illustrate the potential consequences of a double aged phenotype in sarcopenic obesity. Clinically, the modifiable risk factors could be targeted specifically in obesity to allow for increased health span in the aged and sarcopenic obese populations.

Indexed as

Aging, PrematureSarcopeniaAgingAnimalsObesityPhenotypeAgingDiabetesInflammationNitric oxideObesityOxidant stressSarcopenic obesitySkeletal muscle

Identifiers

PMID35471692
PMCPMC9213608
OpenAlexW4224609738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.